Dear E,
As the conference chairperson for the much-anticipated Fierce New Product Planning Summit 2023 on October 16-18 in Boston. I'd like to extend a personal invitation for you to join me, and our esteemed peers from across the industry, to explore key topics in new product planning.
New product planning is the lifeblood of every successful enterprise; it is the bedrock upon which innovation thrives and the discipline guiding us through an ever-changing competitive terrain. Within this dynamic context, we intend to dissect and explore a comprehensive spectrum of topics that are pivotal to success.
The Summit has earned a reputation as the only event dedicated to all key facets of new product planning. These include: pipeline and portfolio management, sustained revenue growth, value creation, forecasting accuracy, strategy alignment and other topics that interest you.
View the agenda here now
Our roster of panels and case studies, meticulously curated with industry experts and thought leaders, promises an engaging and enlightening experience. The Fierce New Product Planning Summit is not merely an event but a convergence of minds united by the pursuit of excellence.
In addition to the robust New Product Planning agenda, we are also co-located with the Fierce Biotech Summit and have aligned all our meals, breaks, and receptions for even greater networking and relationship building.
Every year the Fierce Biotech editorial team evaluates hundreds of early-stage companies from around the world for its annual Fierce 15 list, which is based on a variety of factors such as the strength of its technology, partnerships, venture backers, and a competitive market position. We will be announcing this year's winners during the networking cocktail reception on Monday, October 16th.
I hope you will join us and take advantage of this incredible opportunity for powerful discussions and new connections.
Register now to reserve your spot today and use code CHAIR50 to save 50% off! Don't wait, this offer expires September 13, 2023.
Sincerely,
Geoff Birkett
Chief Commercial Officer
Ensysce Biosciences
